|
1
|
Libby P and Theroux P: Pathophysiology of
coronary artery disease. Circulation. 111:3481–3488. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Williams KJ and Tabas I: Atherosclerosis
and inflammation. Science. 297:521–522. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hansson GK and Libby P: The immune
response in atherosclerosis: A double-edged sword. Nat Rev Immunol.
6:508–519. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hansson GK and Hermansson A: The immune
system in atherosclerosis. Nat Immunol. 12:204–212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilson RC and Doudna JA: Molecular
mechanisms of RNA interference. Annu Rev Biophys. 42:217–239. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hermeking H: The miR-34 family in cancer
and apoptosis. Cell Death Differ. 17:193–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ito T, Yagi S and Yamakuchi M:
MicroRNA-34a regulation of endothelial senescence. Biochem Biophys
Res Commun. 398:735–740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao T, Li J and Chen AF: MicroRNA-34a
induces endothelial progenitor cell senescence and impedes its
angiogenesis via suppressing silent information regulator 1. Am J
Physiol Endocrinol Metab. 299:E110–E116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Welch C, Chen Y and Stallings RL:
MicroRNA-34a functions as a potential tumor suppressor by inducing
apoptosis in neuroblastoma cells. Oncogene. 26:5017–5022. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cole KA, Attiyeh EF, Mosse YP, Laquaglia
MJ, Diskin SJ, Brodeur GM and Maris JM: A functional screen
identifies miR-34a as a candidate neuroblastoma tumor suppressor
gene. Mol Cancer Res. 6:735–742. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fujita Y, Kojima K, Hamada N, Ohhashi R,
Akao Y, Nozawa Y, Deguchi T and Ito M: Effects of miR-34a on cell
growth and chemoresistance in prostate cancer PC3 cells. Biochem
Biophys Res Commun. 377:114–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ji Q, Hao X, Meng Y, Zhang M, Desano J,
Fan D and Xu L: Restoration of tumor suppressor miR-34 inhibits
human p53-mutant gastric cancer tumorspheres. BMC Cancer.
8:2662008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen QR, Yu LR, Tsang P, Wei JS, Song YK,
Cheuk A, Chung JY, Hewitt SM, Veenstra TD and Khan J: Systematic
proteome analysis identifies transcription factor YY1 as a direct
target of miR-34a. J Proteome Res. 10:479–487. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reichert N, Choukrallah MA and Matthias P:
Multiple roles of class I HDACs in proliferation, differentiation
and development. Cell Mol Life Sci. 69:2173–2187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jurkin J, Zupkovitz G, Lagger S,
Grausenburger R, Hagelkruys A, Kenner L and Seiser C: Distinct and
redundant functions of histone deacetylases HDAC1 and HDAC2 in
proliferation and tumorigenesis. Cell Cycle. 10:406–412. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haberland M, Montgomery RL and Olson EN:
The many roles of histone deacetylases in development and
physiology: Implications for disease and therapy. Nat Rev Genet.
10:32–42. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Zhao H, Zhou X and Song L:
Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes
colon cancer cells to 5-fluorouracil. Mol Med Rep. 11:577–582.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Russo A, Saide A, Cagliani R, Cantile M,
Botti G and Russo G: rpL3 promotes the apoptosis of p53 mutated
lung cancer cells by down-regulating CBS and NFκB upon 5-FU
treatment. Sci Rep. 6:383692016. View Article : Google Scholar : PubMed/NCBI
|
